4db80f32 c3b5 11ed aad1 0210609a3fe2 1 e1749562679616
‹ Back

Growth in Biotech: Argenx’s E2E Supply Network Planning Optimization

10 Jun 2025

The customer

Argenx is a global biotech company specializing in the development of innovative, antibody-based therapies for rare autoimmune diseases. With estimated 2024 revenues exceeding €2.2 billion and a strong growth trajectory, argenx has established a commercial presence in over 30 countries.

Challenges

  • Difficulties in aligning supply chain planning across different regions and CMO partners
  • Time-intensive & complex to run what-if scenarios for demand, supply or production disruptions
  • Lacking ability to run end-to-end optimization within supply network planning
  • No integration between long-term network planning & order management

Solution

Anaplan Implementation

  • Network modelling and optimization across all manufacturing sites
  • Scenario capabilities to evaluate demand/supply shifts, delays, or market expansions
  • Automated order creation through bi-directional integration with the ERP
  • Exception management to flag supply gaps, overstock, or planning conflicts

Results

  • Full end-to-end visibility & control across the global external manufacturing network

  • Ability to run on-the-fly scenarios to simulate demand, supply, or market changes

  • Reduction of planning errors and elimination of manual processes

  • Faster planning cycle through optimized plan generation & automated order creation

  • Strong foundation to support future product launches and scale planning capabilities across  brands

Curious to hear the story first-hand?

Watch Now
Anaplan rebrand bluecrux series argenx banners social e1748850597274

Want to see Anaplan in action?

Get in touch

Other Case Studies